OncoMatch/Clinical Trials/NCT06385691

Study Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer.

Is NCT06385691 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies non-drug interventions for gastric cancer.

Phase 2RecruitingCentre Leon BerardNCT06385691Data as of May 2026

This is a prospective, single-center, single-arm Phase II study evaluating the efficacy of the myDIET software tool in the nutritional management of patients with localized and resectable esogastric junction cancer.

Check if I qualify

Extracted eligibility criteria

Cancer type

Gastric Cancer

Performance status

ECOG 0–2(Ambulatory, capable of self-care)

Prior therapy

Must have received: platinum-based chemotherapy (oxaliplatin) — perioperative

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify